T 1653/18 of 08.02.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T165318.20220208
- Date of decision
- 8 February 2022
- Case number
- T 1653/18
- Petition for review of
- -
- Application number
- 10183144.4
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Modified 2' and 3'-nucleoside prodrugs for treating flaviridae infections
- Applicant name
- IDENIX Pharmaceuticals, Inc.
Centre National de la Recherche Scientifique (C.N.R.S.)
UNIVERSITA' DEGLI STUDI DI CAGLIARI
L'Université Montpellier II - Opponent name
- Gilead Sciences, Inc.
Generics (U.K.) Limited - Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)
- Keywords
- Basis of decision - text or agreement to text withdrawn by patent proprietor
- Catchword
- -
- Cited cases
- T 1021/15
- Citing cases
- T 2684/18
Order
For these reasons it is decided that:
The appeal is dismissed.